long intergenic non-protein coding RNA 2433Genealiases: []
Q-omics provides the consensus-scored LINC02433 profile across patient tissues and cancer cell-line models. LINC02433 expression is associated with patient survival in 18 of 34 cancer types, with the highest sampling consensus in LIHC. Among the 18 cancer types available for tumor–normal comparison, LINC02433 is differentially expressed in 7, with the highest sampling consensus in HNSC. Additionally, LINC02433 RNA expression shows 8,220 significant protein co-abundance associations, with the highest sampling consensus in CCRCC. Together, these results highlight LIHC, HNSC, and CCRCC as cancer lineages where LINC02433 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02433 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02433 survival associations across molecular data types. LINC02433 RNA expression shows survival associations in the most cancer types (18). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02433 RNA expression–survival associations across cancer types. High LINC02433 expression shows unfavorable associations in LIHC, BLCA, KIRP and STAD, but favorable associations in ACC and READ. The LIHC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LIHC as the clearest survival context for LINC02433 RNA expression.
This table summarizes LINC02433 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 7. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02433. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02433 shows higher tumor expression in HNSC, LUAD, BRCA, COAD, BLCA and KIRC. The HNSC box plot shows higher LINC02433 RNA expression in tumor versus normal tissue (log2 FC = +0.031, t-test p < 0.001).
This table shows molecular features associated with LINC02433 in patient tissues and cancer cell lines. In patient samples, LINC02433 shows the broadest associations at the RNA and protein expression levels, with CCRCC recurring as the lineage with the largest associated feature set.
